Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL251108 | 0.75 | TRPA1 (0.30) | MEN1POLBKMT2A | |
| SCHEMBL10937384 | 0.71 | MEN1 (0.30) | MEN1POLBKMT2A | |
| SCHEMBL11648239 | 0.71 | AKR1C1 (0.32) | MEN1POLBKMT2A | |
| SCHEMBL999023 | 0.71 | MEN1 (0.30) | MEN1POLBKMT2A | |
| SCHEMBL7839459 | 0.71 | MEN1 (0.30) | MEN1POLBKMT2A | |
| SCHEMBL28161535 | 0.71 | — | — | |
| SCHEMBL9270158 | 0.71 | — | — | |
| SCHEMBL6536454 | 0.71 | ALDH1A1 (0.31) | ALDH1A1TSHRL3MBTL1 | |
| SCHEMBL27866604 | 0.70 | — | — | |
| SCHEMBL8087905 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6387855-B1 | FOR KERATIN FIBERS | L'OREAL S.A. (FR) | 2002-05-14 | — | — | US | claimed |
| EP-3715927-B1 | FIRE RESISTANT OPTICAL FIBRE CABLE WITH HIGH FIBRE COUNT | PRYSMIAN SPA (IT) | 2022-06-15 | — | — | EP | disclosed |
| EP-3715927-A1 | FIRE RESISTANT OPTICAL FIBRE CABLE WITH HIGH FIBRE COUNT | Prysmian S.p.A. (IT) | 2020-09-30 | — | — | EP | disclosed |
| US-10294352-B2 | Curable, highly transparent silicone composition with improved mechanics, for optical components | WACKER CHEMIE AG (DE) | 2019-05-21 | — | — | US | disclosed |
| US-20170321039-A1 | CURABLE, HIGHLY TRANSPARENT SILICONE COMPOSITION WITH IMPROVED MECHANICS, FOR OPTICAL COMPONENTS | WACKER CHEMIE AG (DE) | 2017-11-09 | — | — | US | disclosed |
| US-20100061953-A1 | METHOD FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS AND COMPOSITION CONTAINING A GRAFTED AMINO ACID POLYMER | L'OREAL S.A. (FR) | 2010-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100061953-A1 | METHOD FOR THE COSMETIC TREATMENT OF KERATINIC MATERIALS AND COMPOSITION CONTAINING A GRAFTED AMINO ACID POLYMER | KRT18, CUTA, AADAT | MEN1 1783/4885POLB 962/4885KMT2A 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.